DXP Enterprises, Inc. engages in the business of distributing maintenance, repair, and operating (MRO) products and services to customers serving a variety of end markets. It operates through the ...
Also announced at ASCO was some intriguing new data on circulating tumour DNA (ctDNA) – fragments of genetic material from cancer cells – that can indicate the presence of minimal residual ...
The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products. Ben Hargreaves looks at why insulin’s ...
DXP Enterprises, Inc. (NASDAQ: DXPE) has reported its financial results for the fourth quarter and fiscal year ended December 31, 2024. The company's sales for fiscal 2024 reached $1.8 billion, ...
View DXP Enterprises, Inc. (DXPE) current and estimated P/E ratio data provided by Seeking Alpha.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results